AWM
BMY icon

Ariadne Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Ariadne Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$992K Buy
16,357
+93
+0.6% +$5.42K 0.45% 51
2025
Q4 		$974K Buy
16,264
+8,192
+101% +$394K 0.4% 56
2025
Q3 		$393K Buy
8,072
+1,200
+17% +$56K 0.18% 122
2025
Q2 		$329K Buy
6,872
+1,858
+37% +$91.2K 0.16% 139
2025
Q1 		$233K Sell
5,014
-2,258
-31% -$132K 0.12% 182
2024
Q4 		$404K Buy
7,272
+177
+2% +$9.89K 0.18% 110
2024
Q3 		$388K Buy
+7,095
New +$333K 0.21% 96

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ariadne Wealth Management's BMY Position: Q1 2026 in Review

Ariadne Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 0.57% in Q1 2026, buying an estimated $5.42K and bringing the position to 16,357 shares worth $992K. The position accounts for 0.45% of the portfolio, ranked #51.

Ariadne Wealth Management first reported a position in BMY in Q3 2024 and has held it in 7 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Ariadne Wealth Management held 16,357 shares of Bristol-Myers Squibb worth $992K as of Q1 2026.
  • Ariadne Wealth Management bought 93 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.42K.
  • Bristol-Myers Squibb made up 0.45% of Ariadne Wealth Management's portfolio in Q1 2026, its #51 holding.
  • Ariadne Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 7 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Ariadne Wealth Management's 13F filing for Q1 2026, filed 18 May 2026.